Healthpeak Properties, Inc. (PEAK)
| Market Cap | 16.06B |
| Revenue (ttm) | 1.64B |
| Net Income (ttm) | 411.15M |
| Shares Out | 530.56M |
| EPS (ttm) | 0.77 |
| PE Ratio | 38.71 |
| Forward PE | 80.65 |
| Dividend | $1.20 |
| Dividend Yield | 4.03% |
| Trading Day | March 5 |
| Last Price | $29.81 |
| Previous Close | $29.49 |
| Change ($) | 0.32 |
| Change (%) | 1.09% |
| Day's Open | 29.59 |
| Day's Range | 28.86 - 29.92 |
| Day's Volume | 3,377,660 |
| 52-Week Range | 17.70 - 32.37 |
These are the REITs with the best value, fastest growth, and most momentum for March 2021.
High COVID-related expenses hinder bottom-line growth for Healthpeak (PEAK) in the fourth quarter. The company also issues soft guidance for 2021.
Healthpeak (PEAK) delivered FFO and revenue surprises of 2.50% and -27.56%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
DENVER, Feb. 9, 2021 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) today announced results for the fourth quarter and full year ended December 31, 2020. FOURTH QUARTER 2020 FINANCIA...
Healthpeak (PEAK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
I was paying attention to yield signs in January. Check out my shopping bag.
Healthpeak's (PEAK) investments in life science and medical office assets are anticipated to have curtailed the massive shock of the senior housing segment and aided top-line growth in Q4.
DENVER, Jan. 28, 2021 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) (the "Offeror") today announced the results of its previously announced offers (the "Offers") to purchase for cas...
DENVER, Jan. 27, 2021 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) (the "Offeror") announced today the purchase prices payable in connection with its previously announced tender of...
Galvanized stocks recovered some of last week's losses led by Goldman Sachs' earnings and incoming Treasury Secretary Janet Yellen's expected remarks calling for more stimulus. With all of th...
DENVER, Jan. 15, 2021 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) announced today the tax treatment of its 2020 distributions. The following table summarizes, for income tax purpo...
While seniors housing exposure has crippled healthcare REITs' performance, medical office buildings and life science real estate have emerged more resilient and are grabbing investor attention.
Over halfway through the trading day on Tuesday, and the broad markets have yet to make up their minds.
This healthcare real estate investment trust has transformed itself for the better.
Glenview Capital Management recently disclosed its portfolio updates for the third quarter of 2020, which ended on Sept. 30.
Healthpeak (PEAK) reported earnings 30 days ago. What's next for the stock?
Healthpeak is accelerating a portfolio shift to MOB's and Life Science. The current $1.48 annual dividend is not well supported.
Investors looking to bolster their income portfolios have long looked to dividend-friendly real estate investment trusts (REITs) to get the job done. But recently, the appeal of high-yield REI...
Seth Klarman (Trades, Portfolio), manager of The Baupost Group, has revealed his portfolio for the third quarter. The portfolio saw the addition of many new holdings, including Pershing Square...
Today's vaccine news has some big implications for these businesses.
Healthpeak Properties' (PEAK) CEO Tom Herzog on Q3 2020 Results - Earnings Call Transcript
High COVID-19-related expenses and declining occupancy at its senior housing operating portfolio hinders third-quarter net operating income for Healthpeak (PEAK).
Healthpeak (PEAK) delivered FFO and revenue surprises of 2.56% and -1.49%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
IRVINE, Calif., Nov. 2, 2020 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) today announced results for the third quarter ended September 30, 2020. For the quarter, we generated a ne...
While occupancy and uncollected rent woes are likely to have clouded healthcare, retail and office REITs' Q3 performance, high network investment by carriers are expected to have aided tower R...
Healthpeak's (PEAK) Q3 results are likely to reflect the impacts of a decline in occupancy and higher expenses at its seniors housing faculties.
Healthpeak Properties has seen some challenges in its SHOP segment. However, it has relatively low exposure to SHOP compared to its peers, and has a growing life sciences business segment.
Rents are rising for lab space, vacancies are plunging and research and development, and employment and new development are expanding further, thanks to strong venture capital investment.
I own dozens of stocks, but don't worry much about these five.
Healthpeak's (PEAK) life science properties are benefiting from the robust demand for space amid increasing need to develop coronavirus vaccines. Yet, soft senior housing environment remains a...
Senior housing operators have experienced significant losses this year due to COVID-19 as well as the corresponding recession.
The health care REIT is breaking below support, setting up for a potential 25% fall just as broader markets are hit with volatility.
Healthpeak (PEAK) reported earnings 30 days ago. What's next for the stock?
The following originally appeared on CapitalWatch The story of America is the story of movement.
While healthcare REITs with significant senior housing exposure are bearing the brunt of the coronavirus outbreak, strong life-science asset fundamentals will likely be a driving factor.
When interest rates are slashed to the bone and bonds yield approximately 1%, these monthly dividend stocks offer much-needed respite.
Healthpeak Properties, Inc. (PEAK) CEO Thomas Herzog on Q2 2020 Results - Earnings Call Transcript
Healthpeak's (PEAK) second-quarter results reflect gains from decent cash same-store portfolio NOI growth in life science and medical office segments.
Healthpeak (PEAK) delivered FFO and revenue surprises of 0.00% and -14.43%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
IRVINE, Calif., Aug. 4, 2020 /PRNewswire/ -- Healthpeak Properties, Inc.
IRVINE, Calif., Aug. 4, 2020 /PRNewswire/ -- Healthpeak Properties, Inc.
Healthpeak Properties Remains Robust Despite COVID-19 Outbreak
The coronavirus-led occupancy shocks and rental rate declines across seniors housing properties are expected to have hindered Healthpeak (PEAK) senior-housing segment's Q2 net operating income.
Diversified healthcare REIT Healthpeak Properties made a major misstep a few years ago, but it looks like it's back on its feet today
IRVINE, Calif., July 14, 2020 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) is scheduled to report its second quarter 2020 financial results after the close of trading on the New Yo...
Healthpeak Properties: High-Quality Healthcare Real Estate On Sale
IRVINE, Calif., July 6, 2020 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) announced today that it has published its 9th annual ESG Report covering 2019 environmental, social and go...
As the New York real estate industry navigates a new normal of slow sales and an oversupply of luxury listings, investment interest is coming from an unexpected place — Italy.
About PEAK
Healthpeak Properties is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
| Industry REIT-Healthcare Facilities | |
| CEO Thomas Herzog | Employees 217 |
| Stock Exchange NYSE | Ticker Symbol PEAK |
Financial Performance
In 2020, PEAK's revenue was $1.64 billion, an increase of 32.61% compared to the previous year's $1.24 billion. Earnings were $413.56 million, an increase of 808.33%.
Analyst Forecasts
According to 21 analysts, the average rating for PEAK stock is "Buy." The 12-month stock price forecast is 31.94, which is an increase of 7.15% from the latest price.